Patents by Inventor Fernando BRAVO

Fernando BRAVO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Englerin derivatives for treatment of cancer
    Patent number: 11098054
    Abstract: Disclosed is a compound of formula (I) in which a, R1-R5 and X1 are as described herein. Also disclosed are a pharmaceutical composition containing the compound and a method of using the compound for treating cancer, such as renal cancer.
    Type: Grant
    Filed: July 5, 2018
    Date of Patent: August 24, 2021
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Sciences, Fundacio Institut Catala D'Investigacio Quimica, University of Delaware, University of Leeds, Universitat Rovira I Virgili
    Inventors: John A. Beutler, Antonio Echavarren, William Chain, David Beech, Zhenhua Wu, Jean-Simon Suppo, Fernando Bravo, Hussein Rubaiy
  • ENGLERIN DERIVATIVES FOR TREATMENT OF CANCER
    Publication number: 20200140451
    Abstract: Disclosed is a compound of formula (I) in which a, R1-R5 and X1 are as described herein. Also disclosed are a pharmaceutical composition containing the compound and a method of using the compound for treating cancer, such as renal cancer.
    Type: Application
    Filed: July 5, 2018
    Publication date: May 7, 2020
    Applicants: The United States of America,as represented by the Secretary,Department of Health and Human Services, Fundacio Institut Catala D'Investigacio Quimica, University of Delaware, University of Leeds, Universitat Rovira I Virgili
    Inventors: John A. Beutler, Antonio Echavarren, William Chain, David Beech, Zhenhua Wu, Jean-Simon Suppo, Fernando Bravo, Hussein Rubaiy
  • Epoxyazulene derivatives useful for treating cancer and diabetes
    Patent number: 10287297
    Abstract: Disclosed is a compound of formula (I) in which R1-R5 and X1 are as described herein. Also provided are methods of using a compound of formula (I), including a method of treating cancer and a method of treating diabetes.
    Type: Grant
    Filed: April 13, 2016
    Date of Patent: May 14, 2019
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Fundació Institut Català d'Investigació Quimica (ICIQ), Universitat Rovira i Virgili
    Inventors: John A. Beutler, Antonio M. Echavarren, Laura Lopez, Fernando Bravo, Lorena Riesgo, Tanya Tannaquil Ransom
  • EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER AND DIABETES
    Publication number: 20180127433
    Abstract: Disclosed is a compound of formula (I) in which R1-R5 and X1 are as described herein. Also provided are methods of using a compound of formula (I), including a method of treating cancer and a method of treating diabetes.
    Type: Application
    Filed: April 13, 2016
    Publication date: May 10, 2018
    Applicants: The United States of America, as represented by the Secretary, Department of Health and Human, Fundació Institut Català d'Investigació Química (ICIQ), Universitat Rovira i Virgili
    Inventors: John A. BEUTLER, Antonio M. ECHAVARREN, Laura LOPEZ, Fernando BRAVO, Lorena RIESGO, Tanya Tannaquil RANSOM